CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED
Get an alert when CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£3.5B
-0.5% vs 2024
Employees
0
Average over period
Profit before tax
-£16M
Period ending 2025-12-31
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | — | — | — | — | |
| Profit before tax | -£1,000,000 | £0 | -£16,000,000 | — | |
| Net profit | -£1,000,000 | £0 | -£16,000,000 | — | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | — | — | — | — | |
| Net assets | £3,497,000,000 | £3,497,000,000 | £3,481,000,000 | -0.5% | |
| Equity | £3,497,000,000 | £3,497,000,000 | £3,481,000,000 | -0.5% | |
| Average employees | 0 | 0 | 0 | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Gearing (liabilities / total assets) | 0.0% | 0.0% | 0.0% |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED 2011-09-01 → present
- CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 1996-08-22 → 2011-09-01
- INTERCEDE 1186 LIMITED 1996-08-05 → 1996-08-22
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Consolidated group
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Financial Statements have been prepared on the going concern basis, which assumes that continued funding is available to the Company. The Directors, in concluding that the going concern basis is appropriate, have received from AstraZeneca PLC a letter of support confirming that AstraZeneca PLC will continue to provide the financial resources required to fund the Company's operations for the foreseeable future and at least 12 months from the date of signing the Financial Statements. On the basis of their assessment, the Company's Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the Financial Statements.”
Group structure
- CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED · parent
- MedImmune Limited 100%
- Optein, Inc. 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 33 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JOHNSTONE, Camilla Jane | Secretary | 2019-09-06 | — | — |
| BOWDEN, Matthew Shaun | Director | 2019-02-27 | Dec 1977 | British |
| COLLINS, Iain Alistair | Director | 2017-05-31 | Dec 1970 | British |
| TATTERSALL, Hannah Victoria | Director | 2025-05-01 | Jul 1987 | British |
Show 33 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CONACHER, Matthew Ian | Secretary | 2017-03-16 | 2019-09-06 |
| HOSKINS, Justin Wilbert | Secretary | 2005-03-31 | 2006-06-30 |
| KEMP, Adrian Charles Noel | Secretary | 2009-01-01 | 2017-03-16 |
| MELLETT, Diane | Secretary | 1997-12-12 | 2005-03-31 |
| MUSKER, Graeme Harold Rankine | Secretary | 2006-06-30 | 2008-12-31 |
| NIXON, Anthony Michael | Secretary | 1996-08-22 | 1997-12-12 |
| MITRE SECRETARIES LIMITED | Corporate Nominee Secretary | 1996-08-05 | 1996-08-22 |
| ASTON, John Christopher | Director | 1996-10-18 | 2006-06-30 |
| ASTON, Roger | Director | 1996-12-20 | 1997-12-31 |
| BICKER, Uwe, Professor | Director | 1999-02-06 | 2006-02-03 |
| BRIMICOMBE, Ian Martin David | Director | 2006-06-22 | 2017-05-31 |
| BROWN, John Robert, Dr | Director | 2005-09-12 | 2006-06-30 |
| CHAMBRE, Peter Alan | Director | 2002-04-08 | 2006-06-30 |
| CHISWELL, David | Director | 1996-08-22 | 2002-03-31 |
| CUMMING, Alistair Cameron David | Director | 1998-03-01 | 1998-11-29 |
| FOGHT, James Loren | Director | 1996-12-20 | 2003-02-07 |
| GARLAND, Peter Bryan, Professor | Director | 1996-09-10 | 2004-01-30 |
| GLOVER, David Roy, Doctor | Director | 1997-07-11 | 2005-02-04 |
| GRADY, Shaun Francis | Director | 2006-06-22 | 2009-04-06 |
| JACKSON-TURNER, Katie Louise | Director | 2017-03-16 | 2019-02-27 |
| JOHNSON, Kevin Stuart, Dr | Director | 1997-07-11 | 2003-06-19 |
| KEMP, Adrian Charles Noel | Director | 2006-06-22 | 2025-05-01 |
| KLUG, Aaron, Professor Sir | Director | 1996-12-20 | 2006-02-03 |
| MARSHALL, Christopher John | Director | 2004-09-24 | 2006-06-30 |
| MELLETT, Diane | Director | 2005-02-04 | 2006-06-30 |
| MUSKER, Graeme Harold Rankine | Director | 2006-06-22 | 2008-12-31 |
| NICHOLSON, Paul Anthony, Doctor | Director | 1999-02-06 | 2006-06-30 |
| REEVES, Barbara | Nominee Director | 1996-08-05 | 1996-08-22 |
| RINGROSE, Peter Stuart, Doctor | Director | 2003-02-10 | 2006-06-30 |
| STAVLING, Ake Bo Tage | Director | 2002-12-02 | 2006-06-30 |
| STOCKER, John Wilcox, Doctor | Director | 1996-12-20 | 2006-06-30 |
| WEISBROD, Stuart T | Director | 1996-12-20 | 1998-09-30 |
| WINDMILL, Robert John | Nominee Director | 1996-08-05 | 1996-08-22 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Astrazeneca Treasury Limited | Corporate entity | Shares 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 490 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-11-27 MA Memorandum articles
- 2024-11-27 RESOLUTIONS Resolution
- 2024-11-20 CC04 Statement of companys objects
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-19 | AA | accounts | Accounts with accounts type full | |
| 2025-08-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-02 | AA | accounts | Accounts with accounts type full | |
| 2025-05-02 | AP01 | officers | Appoint person director company with name date | |
| 2025-05-01 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-27 | MA | incorporation | Memorandum articles | |
| 2024-11-27 | RESOLUTIONS | resolution | Resolution | |
| 2024-11-20 | CC04 | change-of-constitution | Statement of companys objects | |
| 2024-08-21 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-05-28 | AA | accounts | Accounts with accounts type full | |
| 2023-10-25 | SH01 | capital | Capital allotment shares | |
| 2023-08-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-03 | AA | accounts | Accounts with accounts type full | |
| 2022-08-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-16 | CH01 | officers | Change person director company with change date | |
| 2022-08-04 | AA | accounts | Accounts with accounts type full | |
| 2021-12-06 | CH01 | officers | Change person director company with change date | |
| 2021-08-27 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-08-06 | AA | accounts | Accounts with accounts type full | |
| 2020-12-19 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.